Cargando…
Enrichment of circulating melanoma cells (CMCs) using negative selection from patients with metastatic melanoma
Circulating tumor cells have emerged as prognostic biomarkers in the treatment of metastatic cancers of epithelial origins viz., breast, colorectal and prostate. These tumors express Epithelial Cell Adhesion Molecule (EpCAM) on their cell surface which is used as an antigen for immunoaffinity captur...
Autores principales: | Joshi, Powrnima, Jacobs, Barbara, Derakhshan, Adeeb, Moore, Lee R., Elson, Paul, Triozzi, Pierre L., Borden, Ernest, Zborowski, Maciej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058018/ https://www.ncbi.nlm.nih.gov/pubmed/24811334 |
Ejemplares similares
-
Circulating Melanoma Cells: Scoping the Target
por: Joshi, Powrnima, et al.
Publicado: (2013) -
iTRAQ Quantitative Proteomic Comparison of Metastatic and Non-Metastatic Uveal Melanoma Tumors
por: Crabb, John W., et al.
Publicado: (2015) -
Synthesis and Characterization of PU/PLCL/CMCS Electrospun Scaffolds for Skin Tissue Engineering
por: Gao, Xiang, et al.
Publicado: (2022) -
Phosphatase inhibitor, sodium stibogluconate, in combination with interferon (IFN) alpha 2b: phase I trials to identify pharmacodynamic and clinical effects
por: Yi, Taolin, et al.
Publicado: (2011) -
The association of blood angioregulatory microRNA levels with circulating endothelial cells and angiogenic proteins in patients receiving dacarbazine and interferon
por: Triozzi, Pierre L, et al.
Publicado: (2012)